🇮🇳IN
Sign In
BI

BIOFILCHEM

NSE

Biofil Chemicals & Pharmaceuticals Limited

₹29.34

-0.92(-3.04%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector−₹5,497 Crnet foreign selling
2026-10-01 to 2026-10-15

This is the flow into the whole Healthcare sector, not into BIOFILCHEM. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

BIOFILCHEM exposure summary

In its latest segment disclosure (Dec 2024), Pharma Unit was the largest segment at 84.9% of segment revenue, followed by Chemicals Division at 15.1%.

Largest segmentPharma Unit · 84.9%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer